Peter A Kouides MD
Clotting Disorder, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias
Medical and research director, Mary M. Gooley Hemophilia center, Clinical Professor of Medicine University of Rochester School of Medicine
Join to View Full Profile
1425 Portland AveRochester, NY 14621
Phone+1 585-922-4020
Fax+1 585-563-1832
Dr. Kouides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Peter Kouides is an oncologist in Rochester, NY and is affiliated with Rochester General Hospital. He received his medical degree from State University of New York Upstate Medical University and has been in practice 31 years. He specializes in hematologic oncology and is experienced in thrombotic disorders, bleeding disorders, general / benign hematology, and anemia.
Education & Training
University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1993
Tufts Medical CenterResidency, Internal Medicine, 1986 - 1989
SUNY Upstate Medical UniversityClass of 1986
Certifications & Licensure
NY State Medical License 1989 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders Start of enrollment: 2003 Apr 01
- Monitoring Minimal Residual Disease of Patients with Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
- Von Willebrand Factor in Pregnancy (VIP) Study Start of enrollment: 2019 Oct 12
Publications & Presentations
PubMed
- 1 citationsBreaking barriers in haemophilia A care: One-year real-world experience with emicizumab prophylaxis at Civil Service Hospital, Kathmandu, Nepal.Bishesh Sharma Poudyal, Nikesh Bajracharya, Bishal Paudel, Bikram Karki, Devendra Acharya
Haemophilia. 2025-03-01 - Delphi consensus recommendations for neuraxial anesthesia in adults with platelet disorders and coagulation defects: communication from the ISTH SSC Subcommittee on vo...Wynn Peterson, Rachel Martin, Donald Arnold, Brendan Carvalho, Adam Cuker
Journal of Thrombosis and Haemostasis. 2025-02-12 - Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study.Leslie Skeith, Paula James, Peter Kouides, Kelsey Uminski, Lisa Duffett
Journal of Thrombosis and Haemostasis. 2025-02-01
Abstracts/Posters
- Association of Obesity on Laboratory Profiles of Individuals with Type 1 Von Willebrand Disease and Low VWF in the Athn DatasetPeter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center StudyPeter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Congenital FVIII/IX or VWF Deficiency Does Confer a Lower Rate of Myocardial Infarction-Related Mortality Despite Decreased Cardiovascular InterventionsPeter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
